01.08.24 |
Novo Nordisk Neutral |
UBS AG |
|
31.07.24 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
19.07.24 |
Novo Nordisk Buy |
Goldman Sachs Group Inc. |
|
12.07.24 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
11.07.24 |
Novo Nordisk Buy |
Goldman Sachs Group Inc. |
|
11.07.24 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
10.07.24 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
04.07.24 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
03.07.24 |
Novo Nordisk Hold |
Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
|
03.07.24 |
Novo Nordisk Buy |
Goldman Sachs Group Inc. |
|
02.07.24 |
Novo Nordisk Underperform |
Jefferies & Company Inc. |
|
01.07.24 |
A.P. Moeller - Maersk A-S Underperform |
Bernstein Research |
|
28.06.24 |
Novo Nordisk Neutral |
UBS AG |
|
27.06.24 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
27.06.24 |
Novo Nordisk Buy |
Goldman Sachs Group Inc. |
|
25.06.24 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
24.06.24 |
Novo Nordisk Underperform |
Jefferies & Company Inc. |
|
24.06.24 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
20.06.24 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
14.06.24 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
30.05.24 |
Novo Nordisk Buy |
Goldman Sachs Group Inc. |
|
28.05.24 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
24.05.24 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
15.05.24 |
Novo Nordisk Neutral |
UBS AG |
|
14.05.24 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
14.05.24 |
Novo Nordisk Neutral |
UBS AG |
|
08.05.24 |
Novo Nordisk Hold |
Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
|
07.05.24 |
Novo Nordisk Overweight |
Barclays Capital |
|
06.05.24 |
Novo Nordisk Neutral |
UBS AG |
|
03.05.24 |
Novo Nordisk Halten |
DZ BANK |
|
03.05.24 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
03.05.24 |
A.P. Moeller - Maersk A-S Neutral |
Goldman Sachs Group Inc. |
|
03.05.24 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
02.05.24 |
Novo Nordisk Overweight |
Barclays Capital |
|
02.05.24 |
A.P. Moeller - Maersk A-S Neutral |
Goldman Sachs Group Inc. |
|
02.05.24 |
Novo Nordisk Neutral |
UBS AG |
|
02.05.24 |
A.P. Moeller - Maersk A-S Buy |
UBS AG |
|
02.05.24 |
A.P. Moeller - Maersk A-S Underperform |
Bernstein Research |
|
02.05.24 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
02.05.24 |
Novo Nordisk Underperform |
Jefferies & Company Inc. |
|